Repurposing Tin Mesoporphyrin as an Immune Checkpoint Inhibitor Shows Therapeutic Efficacy in Preclinical Models of Cancer
暂无分享，去创建一个
A. Tutt | A. Grigoriadis | J. Spicer | C. Gillett | S. Lall | S. Madden | F. Dazzi | M. van Hemelrijck | J. Burchell | J. N. Arnold | S. Diebold | S. Kordasti | James W. Opzoomer | Jonathan Caron | Tamara Muliaditan | P. Kosti | Mary A. Okesola